Search - tctmd.com

Displaying 901 - 920 of 2707

Sort: Relevancy | Date

Presentation TCT 2021

Outcomes of Pulmonary Artery Denervation for Treatment of PAH

Presenter: Gregg Stone

November 06, 2021

Presentation TCT 2021

Update On The Latest Clinical Evidence

Presenter: Ajay Kirtane

November 06, 2021

Presentation TCT 2021

Get To Know Ultrasound RDN (uRDN)

Presenter: Chandan Devireddy

November 06, 2021

Presentation TCT 2021

Establishing Consensus: US Guidance Updates

Presenter: Eric Secemsky

November 06, 2021

Presentation TCT 2021

Leading with Evidence: Latest Data on Renal Denervation

Presenter: NULL

November 06, 2021

Presentation TCT 2021

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Presenter: Daniel Burkhoff

November 05, 2021

Presentation TCT 2021

Latest Evidence in the SPYRAL-HTN Clinical Program

Presenter: NULL

November 05, 2021

Presentation TCT 2021

TCT 105: Impact of pulmonary hypertension differentiation on the outcome of patients undergoing MitraClip® therapy

Presenter: Tobias Schmidt

November 05, 2021

Presentation TCT 2021

Adequacy of Blood Pressure Control in High-Risk Hypertensive Patients: The DEGREE Study

Presenter: Victor Zeijen

November 04, 2021

Presentation TCT 2021

Cardiac Neuromodulation Therapy reduces Systolic Blood Pressure and Pulse Pressure in Patients With Isolated Systolic Hypertension in a Randomized Double-Blind Study

Presenter: Daniel Burkhoff

November 04, 2021

Presentation TCT 2021

Best Practices for the Future Implementation of Interventional Therapies for Hypertension

Presenter: Michael Bloch

November 04, 2021

Presentation TCT 2021

Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for a Third Medication!

Presenter: Herbert D. Aronow

November 04, 2021

Presentation TCT 2021

Pacemaker-Mediated Baroreflex Stimulation: New Clinical Data and Further Follow-up

Presenter: Daniel Burkhoff

November 04, 2021

Presentation TCT 2021

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Presenter: David E. Kandzari

November 04, 2021

Presentation TCT 2021

Patient Preferences for Interventional versus Pharmaceutical Treatments Among U.S. Adults with Uncontrolled Hypertension

Presenter: Michael A. Weber

November 04, 2021

Presentation TCT 2021

Dietary and Pharmacologic Approaches to Hypertension Management in 2021 – What’s New and What’s Changed

Presenter: Debbie Cohen

November 04, 2021

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

Presentation TCT 2021

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

Presenter: Ajay Kirtane

November 04, 2021

Presentation TCT 2021

TCT 677: Renal denervation in a young patient with malignant hypertension

Presenter: Maria Antonieta Lopes

November 04, 2021

Presentation TCT 2021

TCT 676: Emergent Thrombectomy of Right Ventricular Thrombus and Massive Pulmonary Emboli using Inari FlowTriever

Presenter: Qasim Jehangir

November 04, 2021

Advertisement

Outcomes of Pulmonary Artery Denervation for Treatment of PAH

Update On The Latest Clinical Evidence

Get To Know Ultrasound RDN (uRDN)

Establishing Consensus: US Guidance Updates

Leading with Evidence: Latest Data on Renal Denervation

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Latest Evidence in the SPYRAL-HTN Clinical Program

TCT 105: Impact of pulmonary hypertension differentiation on the outcome of patients undergoing MitraClip® therapy

Adequacy of Blood Pressure Control in High-Risk Hypertensive Patients: The DEGREE Study

Cardiac Neuromodulation Therapy reduces Systolic Blood Pressure and Pulse Pressure in Patients With Isolated Systolic Hypertension in a Randomized Double-Blind Study

Best Practices for the Future Implementation of Interventional Therapies for Hypertension

Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for a Third Medication!

Pacemaker-Mediated Baroreflex Stimulation: New Clinical Data and Further Follow-up

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Patient Preferences for Interventional versus Pharmaceutical Treatments Among U.S. Adults with Uncontrolled Hypertension

Dietary and Pharmacologic Approaches to Hypertension Management in 2021 – What’s New and What’s Changed

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

TCT 677: Renal denervation in a young patient with malignant hypertension

TCT 676: Emergent Thrombectomy of Right Ventricular Thrombus and Massive Pulmonary Emboli using Inari FlowTriever

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content